+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Adenosine triphosphate: a potential therapy for hypoxic pulmonary hypertension



Adenosine triphosphate: a potential therapy for hypoxic pulmonary hypertension



Journal of Pediatric Surgery 23(12): 1154-1160



In this study we investigated whether a low-dose infusion of ATP-MgCl2 could ameliorate the pulmonary hypertension resulting from hypoxic pulmonary vasoconstriction. Three-week-old piglets were anesthetized, intubated, ventilated with room air, and cannulated for the measurement of pulmonary and systemic arterial pressure and pulmonary artery flow (cardiac output). The ventilator inflow was then changed to a mixture containing 10% oxygen, 4% CO2, and balance nitrogen. Serial infusions of ATP-MgCl2 at 0.1, 0.5 and 1.0 mg/kg/min were compared to preinfusion hypoxia baselines. Hypoxia alone produced a significant elevation in pulmonary artery pressure. Although all dose rates of ATP-MgCl2 produced a significant decrease (30%) in mean pulmonary artery pressure, we observed a maximum decrease in MPAP at the lowest rate of ATP infusion. Pulmonary artery flow rose slightly during ATP infusion; therefore, it was the change in pulmonary vascular resistance that accounted for the decrease in pulmonary artery pressure. In contrast, the systemic pressure was significantly decreased only during the 1.0 mg/kg/min infusion. The predominant pulmonary effects are a result of the virtual clearance of ATP-MgCl2 in a single pass through the circulation. Adenosine in the presence or absence of MgCl2 produced only a 10% reduction in mean pulmonary artery pressure, and MgCl2 had no effect when infused alone. From these results, we conclude that a low-dose infusion of ATP-MgCl2 could ameliorate the vasoconstriction associated with hypoxic pulmonary hypertension without significant deleterious systemic side effects.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039187341

Download citation: RISBibTeXText

PMID: 3236180

DOI: 10.1016/s0022-3468(88)80332-4


Related references

Adenosine triphosphate (ATP) treatment of hypoxic pulmonary hypertension (HPH): comparison of dose dependence in pulmonary and renal circulations. Journal of Surgical Research 46(4): 374-379, 1989

Adenosine triphosphate therapy in a piglet model of group B Streptococcus induced pulmonary hypertension. Clinical Research 40(4): 824A, 1992

A calcium ion-dependent adenosine triphosphate pyrophosphohydrolase in plasma membrane from rat liver. Demonstration that the adenosine triphosphate analogues adenosine 5'-[betagamma-imido]triphosphate and adenosine 5'-[betagamma-methylene]-triphosphate are substrates for the enzyme. Biochemical Journal 171(3): 817-820, 1978

Effect of adenosine triphosphate on membrane potential of myocardial fibers; problem of restitution of membrane potential of the calcium-paralyzed frog heart by adenosine triphosphate. Pflugers Archiv für die Gesamte Physiologie des Menschen und der Tiere 267(2): 200-205, 1958

Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: the UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) trial. European Heart Journal 36(46): 3276-3287, 2016

The conversion of adenosine 5'-phosphate into adenosine triphosphate as catalysed by adenosine triphosphate--creatine phosphotransferase and adenosine triphosphate--adenosine monophosphate phosphotransferase in the presence of phosphocreatine. Biochemical Journal 86: 344-350, 1963

Adenosine triphosphate treatment for meconium aspiration-induced pulmonary hypertension in pigs. Acta Physiologica Scandinavica 160(3): 283-289, 1997

Adenosine triphosphate A potent and selective vasodilator for pulmonary hypertension after cardiopulmonary bypass. Surgical Forum 43(0): 274-276, 1992

Intravenous adenosine for refractory pulmonary hypertension in a low-weight premature newborn: a potential new drug for rescue therapy. Pediatric Critical Care Medicine 7(4): 380-382, 2006

Studies on Adenosine Triphosphate-Adenosine Triphosphate Transphosphorylases. V. Carboxyl-Terminal Sequences of Adenosine Triphosphate-Creatine Transphosphorylase and of Adenosine 5'-Phosphate Transphosphorylase (Myokinase). Journal of Biological Chemistry 239: 460-467, 1964

Adenosine monophosphate-activated protein kinase is required for pulmonary artery smooth muscle cell survival and the development of hypoxic pulmonary hypertension. American Journal of Respiratory Cell and Molecular Biology 49(4): 609-618, 2014

Hypoxic pulmonary hypertension is prevented by phenyl isopropyl adenosine pia. Clinical Research 36(1): 50A, 1988

Adenosine 5'-triphosphate, adenosine and endothelium-derived relaxing factor in hypoxic vasodilatation of the heart. European Journal of Pharmacology 165(2-3): 323-326, 1989

Dose-related response of adenosine in hypoxic pulmonary hypertension in canines. Hua Xi Yi Ke Da Xue Xue Bao 30(2): 162-4, 173, 2002

Systemic and myocardial effects of ATP and adenosine during hypoxic pulmonary hypertension in lambs. Pediatric Research 36(1 Pt 1): 41-48, 1994